Dr. Jyotsna Priyam
IIT Mandi · ICGEB · AI-Driven Digital Health · Founder, Biomedical AI Platforms
One of the Most Consequential Years for Cancer Treatment, Ever
Is 2026 really a turning point for cancer treatment, or does it just feel that way? STAT makes a compelling case for the former.
FDA Approves Daraxonrasib, First Drug to Directly Attack Pancreatic Cancer's Genetic Driver
For decades, mutant KRAS was called undruggable. A newly approved pancreatic cancer pill just proved that label wrong.